Medicine Safety

Generic vs Branded Medicines: Bioequivalence, Pack Checks and Country Approval

Learn which parts of a medicine pack to compare and where to verify the exact product for your market.

By Global Medicines ExportUpdated: Educational article

Pack comparison

How to check two medicine packs side by side

Read the original dispensing label, the proposed pack and its leaflet. Bring the details to a pharmacist if a line differs or is unclear.

What a medicine match requires

FieldExample of what to recordQuestion to resolve
Active ingredientEach ingredient in a combination tabletDo all ingredients match the prescription?
Strength and unitsMilligrams per tablet or milligrams per millilitreIs the amount stated per unit, per millilitre or per container?
Form and routeOral tablet, eye drop or injectable solutionIs the proposed form intended for the same route?
Release or deviceImmediate release, extended release, pen or vialDo the actual instructions and delivery method match?
Product identityName, authorisation holder and local reference numberDoes the official record describe this exact presentation?
Supplied packPack count, batch, expiry and storageCan the dispensing or procurement team verify the supplied batch?

Where to start a product search

MarketOfficial sourceWhat to look for
United StatesFDA Orange BookExact strength, dosage form, applicant, application and any relevant therapeutic equivalence code
United KingdomMHRA ProductsProduct licence and the corresponding product information and leaflet
AustraliaTGA Australian Register of Therapeutic GoodsExact entry, sponsor and current product documents
New ZealandMedsafe Product/Application SearchExact product and current regulatory status
FranceBase de Données Publique des MédicamentsFrench product record, presentation and official leaflet

What is the difference between a generic name and a brand name?

The active ingredient is the substance that produces the intended effect. A brand name identifies a product sold by a particular company. A generic product can also have a brand name. Use the active ingredient line and the exact presentation to establish what each pack contains.

In the United States, FDA evaluates a proposed generic against a reference product. Its generic requirements cover the active ingredient, strength, dosage form, route, quality and performance, with permitted differences in features such as appearance or certain inactive ingredients. The approval applies to the product reviewed by the regulator.

What does bioequivalence tell you?

For many medicines that act after entering the bloodstream, regulators compare how quickly and how much of the active drug becomes available under defined study conditions. They assess those measurements against criteria for the particular product. Other products can require different evidence, for example when the medicine acts locally or uses a complex delivery system.

A lower price or different tablet colour can be compatible with an approved generic. If you have an allergy or sensitivity to an inactive ingredient, bring the new leaflet to the pharmacist. Ask them to check the exact ingredient and the available alternatives.

Why the same number can describe different products

Read the unit alongside the number. A concentration describes the amount in a volume, while total contents describe the whole container. On a combination pack, keep each strength next to its own ingredient. The dapagliflozin and metformin combination guide shows how to read two strengths on one tablet label.

Check how the medicine releases its ingredient. For example, a metformin pack marked extended release needs the formulation checked alongside the strength. The metformin release forms guide explains common pack wording. Confirm any change with the dispensing pharmacist, including whether the instructions about taking, splitting or crushing the tablet differ.

How to look up approval for a particular country

Start with the regulator for the country where the exact product will be used. Search the product name and active ingredient, then match the strength, dosage form and application or licence details. Review the status and local product information. A product may have a familiar brand name in several markets with different presentations or instructions.

In the United States, the Orange Book provides approval and therapeutic equivalence information for products within its scope. A pharmacist can interpret an equivalence code for the identified product. In the European Union, medicines can have national authorisations. When checking a product for France, consult the French public database as well as relevant EU information. If a search yields no match, ask the regulator, pharmacist or receiving organisation to verify the record.

What to do when the pharmacy supplies a different-looking pack

Compare the dispensing label and leaflet before taking it. Ask the pharmacist to explain the name or appearance change, especially if the strength, device or release wording looks different. Have the earlier and current packs or photos available. Some treatments require extra care with switching because the formulation, device or monitoring plan matters.

If symptoms change after a switch, note the product, date and what happened, and contact the treating or dispensing team. They can assess the medicine and the underlying condition and, where appropriate, report a suspected adverse effect or quality issue. Follow their instructions before making a further change.

What a procurement team can request before accepting a pack

Specify the exact ingredient, strength, presentation, pack size and destination. Ask for the currently applicable product information, authorisation details and batch documents your receiving organisation requires. Check expiry and storage instructions for the offered pack. Keep the approval and quality checks specific to the identified product and batch.

The catalogue, a manufacturer document and the destination regulatory record answer different questions. Ask the receiving pharmacy or compliance team to confirm any local substitution, dispensing and import requirements. The medicine export guide provides a starting point for the documents to discuss.

Export product support

Need product, pack, and documentation details?

Global Medicines Export can support international B2B enquiries for product availability, strengths, pack information, quotation coordination, and shipment documentation review.

Common questions

Can a generic have a brand name?

Yes. Use the active ingredient, formulation and local product record to identify what the brand name describes.

Can an approved generic look or taste different?

Yes. Appearance and some inactive ingredients may differ. Ask a pharmacist about an unfamiliar pack or a known ingredient sensitivity.

Are two tablets interchangeable if the milligrams match?

That comparison needs the full ingredient list, dosage form, release type, product record and prescription. Have a pharmacist confirm a proposed substitution.

Can I search for equivalence from a product name alone?

Use the full presentation and application or licence details where available. Broad name results may cover more than one strength, formulation or authorisation holder.

Does a listing prove the same pack is approved abroad?

Verify the exact presentation with the destination authority. The local record and applicable supply rules are separate checks.

What if I think the new product has caused a problem?

Contact your pharmacist or prescriber with both pack names, your symptoms and the change date. Keep the packaging available to support a batch or product check.

Important medical note

This article is for general educational information only. It is not medical advice, diagnosis, or a treatment plan. Medicines should be used only under the guidance of a qualified healthcare professional. Product availability, export documentation, and quotation support do not imply that a medicine is appropriate for any individual patient.

References